Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Mbio|April 9, 2021
Early Emergence and Long-Term Persistence of HIV-Infected T-Cell Clones in ChildrenMichael J Bale, Mary Grace Katusiime, Daria Wells, et al.
Journal of the International AIDS Society|November 11, 2021
HIV-1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trialUrvi M Parikh, Kerri J Penrose, Amy L Heaps, et al.
JCI Insight|September 6, 2019
Linked dual-class HIV resistance mutations are associated with treatment failureValerie F Boltz, Wei Shao, Michael J Bale, et al.
The Journal of Clinical Investigation|September 12, 2017
No evidence of HIV replication in children on antiretroviral therapyGert U Van Zyl, Mary Grace Katusiime, Ann Wiegand, et al.
The Journal of Infectious Diseases|October 14, 2022
HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV PreventionSusan H Eshleman, Jessica M Fogel, Elias K Halvas, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2024
HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNAAdam A Capoferri, Ann Wiegand, Feiyu Hong, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNAAdam A Capoferri, Ann Wiegand, Feiyu Hong, et al.
The Journal of Clinical Investigation|October 5, 2020
HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virusElias K Halvas, Kevin W Joseph, Leah D Brandt, et al.
Open Forum Infectious Diseases|November 3, 2025
Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and Pretreatment Resistance to Lamivudine: a Case Report From HPTN 083Hannah P Moore, Jessica M Fogel, Mark A Marzinke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2026
Prospective HIV RNA screening with long-acting cabotegravir pre-exposure prophylaxis in HPTN 083Raphael J Landovitz, Jessica M Fogel, Fei Gao, et al.
Pageof 4